Prolonged or sustained depletion of microglia with the CSF1R inhibitors has been shown to confer neuroprotection and improve cognitive recovery in experimental models of neurological disorders including acute hippocampal lesion, Alzheimer's disease, and multiple sclerosis 38, 39, 42, 83, 84. The gene discussed is CSF1R; the disease is Alzheimer disease.